HDFC BANK Q4 REVIEW
PAT at Rs 4799 Cr vs Rs 3990 Cr, up 20.2%
NII at Rs 10,658 Cr vs Rs 9,055 Cr, up 17.7%
Net Interest Margin at 4.3%
Other Income at Rs 4229 Cr vs Rs 3446 Cr, Up 22.7%
Operating Profit at Rs 8835 Cr vs Rs 7279 Cr, up 21.3%
LUPIN
Gets USFDA Approval For Generic Xenazine
ICICI BANK
Rejects Claims Of Denying An External Audit
SEBI May Seek Forensic Probe Of ICICI Bank Books, Disclosures
Mulling A Forensic Examination Of Financial Statements & Disclosures
Bank's Chairman MK Sharma Conducted A Secret Inquiry 2 Yrs Ago
Found No Wrongdoing By CEO Chanda Kochhar Over Loans To Videocon
Reports
UNICHEM LAB
Manufacturing Facility At Ghaziabad Inspected By USFDA From April 16-20
Inspection Concluded With Zero Observations
TCS
Enters $ 100 Bn Club